Refine by
Stemline Clinical Outcome Equipment & Supplies
1 equipment items found
by:Stemline Therapeutics, Inc. based inNew York, NEW YORK (USA)
A multicenter Phase 2 trial of SL-701 in adult patients with second-line glioblastoma multiforme (GBM) has been completed, and data suggest that SL-701 is generating a target-specific CD8+ T-cell response, which may be translating into improved clinical outcomes, including improved overall survival, in a subset of patients. Given the safety and efficacy data ...